Hemangioma diagnostic study of choice

Jump to navigation Jump to search

Hemangioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemangioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemangioma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemangioma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemangioma diagnostic study of choice

CDC on Hemangioma diagnostic study of choice

Hemangioma diagnostic study of choice in the news

Blogs on Hemangioma diagnostic study of choice

Directions to Hospitals Treating Hemangioma

Risk calculators and risk factors for Hemangioma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Hemangioma is primarily diagnosed based on the clinical presentation. Investigations such as Ultrasound, CT scan or MRI are needed when hemagioma in organs is suspected. The gold standard for diagnosing lumbosacral hemangioma is MRI.

Diagnostic Study of Choice

Study of choice

Hemangioma is primarily diagnosed based on the clinical presentation.

Diagnostic results

The following findings on performing ultrasound or MRI are confirmatory for hemagioma seen in organs for example hepatic hemangioma:[1][2]

  • Presence of peripheral enhancement of nodules on contrast ultrasound.
  • Presence of smooth, well demarcated mass which has low signal on T1 and high intensity on T2 weighted images.
Sequence of Diagnostic Studies

The various investigations must be performed in the following order:

Name of Diagnostic Criteria

  • There are no established criteria for the diagnosis of hemangioma.

References

  1. McFarland EG, Mayo-Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ (October 1994). "Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging". Radiology. 193 (1): 43–7. doi:10.1148/radiology.193.1.8090920. PMID 8090920.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  2. Drolet BA, Chamlin SL, Garzon MC, Adams D, Baselga E, Haggstrom AN, Holland KE, Horii KA, Juern A, Lucky AW, Mancini AJ, McCuaig C, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Frieden IJ (November 2010). "Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin". J. Pediatr. 157 (5): 789–94. doi:10.1016/j.jpeds.2010.07.054. PMID 20828712.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>

Template:WH Template:WS